ZA908914B - Nmda-blocking pharmaceutical composition - Google Patents

Nmda-blocking pharmaceutical composition

Info

Publication number
ZA908914B
ZA908914B ZA908914A ZA908914A ZA908914B ZA 908914 B ZA908914 B ZA 908914B ZA 908914 A ZA908914 A ZA 908914A ZA 908914 A ZA908914 A ZA 908914A ZA 908914 B ZA908914 B ZA 908914B
Authority
ZA
South Africa
Prior art keywords
designates
chained
straight
branched
nmda
Prior art date
Application number
ZA908914A
Other languages
English (en)
Inventor
Yoel Kloog
Kloog Yoel
Jeffery J Feigenbaum
J Feigenbaum Jeffery
Raphael Mechoulam M Sokolowsky
Mechoulam Mordechai So Raphael
Simon Benita
Benita Simon
Original Assignee
Yissum Res Dev Co
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co, Univ Ramot filed Critical Yissum Res Dev Co
Publication of ZA908914B publication Critical patent/ZA908914B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA908914A 1989-11-07 1990-11-07 Nmda-blocking pharmaceutical composition ZA908914B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation

Publications (1)

Publication Number Publication Date
ZA908914B true ZA908914B (en) 1991-09-25

Family

ID=11060554

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908914A ZA908914B (en) 1989-11-07 1990-11-07 Nmda-blocking pharmaceutical composition

Country Status (11)

Country Link
EP (1) EP0427518B1 (de)
JP (1) JPH0768235B2 (de)
KR (1) KR950005914B1 (de)
AT (1) ATE119898T1 (de)
AU (1) AU631262B2 (de)
CA (1) CA2029419C (de)
DE (1) DE69017839T2 (de)
DK (1) DK0427518T3 (de)
ES (1) ES2071786T3 (de)
IL (1) IL92238A (de)
ZA (1) ZA908914B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
HUP0001062A3 (en) 1996-09-27 2001-09-28 Guilford Pharmaceuticals Inc B Pharmaceutical compositions of phosphinic acid derivatives having naaladase inhibitor acivity
DE19706903A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
IL132784A (en) * 1997-05-07 2004-07-25 Unimed Pharmaceutical Inc Pharmaceutical compositions containing dronabinol
JP2002512188A (ja) * 1998-04-21 2002-04-23 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 抗酸化剤及び神経保護剤としてのカンナビノイド類
EP1928853A4 (de) 2005-09-29 2011-02-16 Amr Technology Inc Verfahren zur herstellung von delta-9-tetrahydrocannabinol
DE102015112092B4 (de) 2015-07-24 2022-03-10 Beko Technologies Gmbh Öl/Wasser-Trennvorrichtung mit Druckluftbeaufschlagung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48824A (en) * 1976-01-12 1980-05-30 Yissum Res Dev Co Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
IL80411A (en) * 1986-10-24 1991-08-16 Raphael Mechoulam Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR910009687A (ko) 1991-06-28
CA2029419C (en) 2004-05-25
IL92238A (en) 1995-07-31
KR950005914B1 (ko) 1995-06-07
AU631262B2 (en) 1992-11-19
DE69017839T2 (de) 1995-08-31
JPH03209377A (ja) 1991-09-12
DE69017839D1 (de) 1995-04-20
EP0427518B1 (de) 1995-03-15
IL92238A0 (de) 1990-07-26
JPH0768235B2 (ja) 1995-07-26
ATE119898T1 (de) 1995-04-15
EP0427518A1 (de) 1991-05-15
DK0427518T3 (da) 1995-07-24
CA2029419A1 (en) 1991-05-08
ES2071786T3 (es) 1995-07-01
AU6583490A (en) 1991-05-30

Similar Documents

Publication Publication Date Title
GR3004902T3 (de)
PH24503A (en) New pharmaceutical compositions having psychotropic activity
EP0168832A3 (en) Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound
BR9904998B1 (pt) derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico e composição farmacêutica.
IL105827A0 (en) Thienobenzodiazepines,their preparation and pharmaceutical compositions containing them
PH25859A (en) Composition for treatment of ischemic disorder
EP0867183A4 (de) Arylpiperidin- und arylpiperazin-derivate und sie enthaltende arzneimittel
TW243449B (de)
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
ZA908914B (en) Nmda-blocking pharmaceutical composition
IL113837A0 (en) [(3,4-difluorophenoxy)methyl] oxirane and its preparation
GR3007401T3 (de)
ZA927381B (en) Nitrogen containing bicyclic compounds, process for preparing them and pharmaceutical compositions containing them.
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
EP0263506A3 (en) Anticonvulsant composition containing amino acid derivative and use of said amino acid derivative
EP0642504A4 (de) (3s, 4s)-delta-6-tetrahydrocannabinol-7-säuren und ihre derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
GR3007219T3 (de)
IL95619A0 (en) N-azabicyclo(3.3.0)octane amides of aromatic acids and pharmaceutical compositions containing them
ES8704081A1 (es) Un procedimiento para la preparacion de nuevas 3-alcoxi-2-(n-pirrolidino)-n-piridil-n-furilmetilpropilaminas
HUT51622A (en) Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance
GR3007498T3 (de)
TW275629B (de)
GR3021200T3 (en) (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them.
ES2133095A1 (es) Acidos alquilidenglutaminicos con propiedades farmaceuticas.